QuData·
What if AI no longer needed real-world data to learn? A breakthrough from Mantis Biotech uses physics-driven “digital twins” to simulate human behavior and generate entirely new realities – potentially accelerating drug discovery, advancing surgical robotics, and unlocking progress in data-scarce domains.
Read full articleArtificial intelligence is restructuring medicine from the exam room to the lab bench. The companies doing it most consequentially are not just digitizing old workflows — they are replacing the underlying logic of how care gets documented, how drugs get discovered, how patients move through the system, and how clinicians access knowledge. From cardiothoracic imaging to whole-brain […]
Insider Brief Inbolt is expanding its AI vision platform with new robot programming and motion-control capabilities designed to reduce the weeks of manual tuning typically required to deploy industrial robots on factory floors. The company pointed out that industrial robot deployment often takes weeks because digital twins rarely match real-world factory conditions precisely. Small variations […]
Biohub's AI toolkit democratizes drug discovery, enabling smaller biotech firms to innovate and compete, potentially transforming the industry. The post Biohub unveils AI world model for protein biology, aiming to reshape drug discovery appeared first on Crypto Briefing.
Insider Brief PRESS RELEASE — Cornerstone Robotics (“CSR”), a leading global innovator in surgical robotics based in Hong Kong, China, is pleased to announce its Sentire® Endoscopic Surgical System (hereinafter “Sentire® Surgical System”) has officially received European Union CE mark certification under the Medical Device Regulation (MDR), covering minimally invasive surgical procedures in General Surgery, Gynecology, […]
Bristol Myers' AI integration could revolutionize pharmaceutical processes, enhancing efficiency and safety while setting new industry standards. The post Bristol Myers deploys Anthropic’s Claude AI to accelerate drug discovery appeared first on Crypto Briefing.
SandboxAQ, the Alphabet spinout chaired by former Google CEO Eric Schmidt, has partnered with Anthropic to embed its large quantitative models directly into Claude, making powerful drug discovery and materials science tools accessible through a natural language interface for the first time. The company’s proprietary LQMs are physics-grounded AI models trained on real-world lab data […]
Quantitative models in drug discovery, materials discovery, science and other sectors will now have much wider distribution via Claude PALO ALTO, Calif., May 18, 2026 — SandboxAQ today announced the […] The post SandboxAQ Integrates Its Quantitative AI Models with Anthropic’s Claude via MCP appeared first on AIwire.
Insider Brief Artificial intelligence is moving from laboratory experiments into the core infrastructure of drug discovery, healthcare delivery and preventive medicine, according to a new global study from Deep Knowledge Group that argues the next competitive divide will not be who develops AI models, but who can deploy them safely and at scale in life […]
